Mokhtari Behnaz, Abdi Arezou, Athari Seyed Zanyar, Nozad-Charoudeh Hojjatollah, Alihemmati Alireza, Badalzadeh Reza
Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Department of Physiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
J Res Med Sci. 2023 Apr 21;28:35. doi: 10.4103/jrms.jrms_120_22. eCollection 2023.
Application of doxorubicin (DOX) in cancer patients is limited due to its dose-dependent toxicity to nontarget tissues such as testis and subsequent infertility. Due to limitation of our knowledge about the mechanisms of DOX toxicity in the reproductive system, reduction of DOX-induced testicular toxicity remains an actual and primary clinical challenge. Considering the potentials of troxerutin (TXR) in generating a protective phenotype in many tissues, we aimed to examine the effect of TXR on DOX-induced testicular toxicity by evaluating the histological changes and the expression of mitochondrial biogenesis genes and microRNA-140 (miR-140).
Twenty-four adult male Wistar rats (250-300 g) were divided in groups with/without DOX and/or TXR. DOX was injected intraperitoneally at 6 consecutive doses over 12 days (cumulative dose: 12 mg/kg). TXR (150 mg/kg/day; orally) was administered for 4 weeks before DOX challenge. One week after the last injection of DOX, testicular histopathological changes, spermatogenesis activity, and expression of mitochondrial biogenesis genes and miR-140 were determined.
DOX challenge significantly increased testicular histopathological changes, decreased testicular expression profiles of sirtuin 1 (SIRT-1) and nuclear respiratory factor-2 (NRF-2), and increased expression of miR-140 ( < 0.05 to < 0.01). Pretreatment of DOX-received rats with TXR significantly reversed testicular histopathological changes, spermatogenesis activity index, and the expression levels of SIRT-1, peroxisome proliferator-activated receptor-γ coactivator 1-alpha (PGC-1α), NRF-2, and miR-140 ( < 0.05 to < 0.01).
Reduction of DOX-induced testicular toxicity following TXR pretreatment was associated with upregulation of SIRT-1/PGC-1α/NRF-2 profiles and better regulation of miR-140 expression. It seems that improving microRNA-mitochondrial biogenesis network can play a role in the beneficial effect of TXR on DOX-induced testicular toxicity.
阿霉素(DOX)在癌症患者中的应用受到限制,因为它对睾丸等非靶组织具有剂量依赖性毒性,进而导致不育。由于我们对DOX在生殖系统中的毒性机制了解有限,降低DOX诱导的睾丸毒性仍然是一个现实且主要的临床挑战。考虑到曲克芦丁(TXR)在许多组织中产生保护表型的潜力,我们旨在通过评估组织学变化以及线粒体生物发生基因和微小RNA - 140(miR - 140)的表达,来研究TXR对DOX诱导的睾丸毒性的影响。
将24只成年雄性Wistar大鼠(250 - 300克)分为接受/未接受DOX和/或TXR的组。在12天内连续6次腹腔注射DOX(累积剂量:12毫克/千克)。在DOX攻击前4周口服给予TXR(150毫克/千克/天)。在最后一次注射DOX后1周,测定睾丸组织病理学变化、精子发生活性以及线粒体生物发生基因和miR - 140的表达。
DOX攻击显著增加了睾丸组织病理学变化,降低了睾丸中沉默调节蛋白1(SIRT - 1)和核呼吸因子 - 2(NRF - 2)的表达谱,并增加了miR - 140的表达(P < 0.05至P < 0.01)。用TXR对接受DOX的大鼠进行预处理可显著逆转睾丸组织病理学变化、精子发生活性指数以及SIRT - 1、过氧化物酶体增殖物激活受体 - γ共激活因子1 - α(PGC - 1α)、NRF - 2和miR - 140的表达水平(P < 0.05至P < 0.01)。
TXR预处理后降低DOX诱导的睾丸毒性与SIRT - 1/PGC - 1α/NRF - 2谱的上调以及miR - 140表达的更好调节有关。似乎改善微小RNA - 线粒体生物发生网络可能在TXR对DOX诱导的睾丸毒性的有益作用中发挥作用。